ஐ.எஸ்.எஸ்.என்: 2165-8048
Klaudia Farkas, Anita Balint, Renata Bor, Laszlo Tiszlavicz, Ferenc Nagy, Zoltan Szepes and Tamas Molnar
Gastrocolic fistula is a rare complication of Crohn’s disease (CD). Due to its asymptomatic presence in the majority of the cases, the diagnosis may be delayed. Anti TNF-α therapy has previously been shown to be effective in the induction and maintenance therapy of fistulizing CD. Anti TNF-α therapy is graded as probably safe in pregnancy. We report a case of gastrocolic fistula secondary to CD in a young pregnant woman who avoided surgery and achieved remission after receiving infliximab induction therapy.